Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board Pharmaceutical Investing
Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea Pharmaceutical Investing
Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases Pharmaceutical Investing
Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial Pharmaceutical Investing
Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19 Pharmaceutical Investing
Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test Biotech Investing
BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 Biotech Investing
